Is HBsAg Loss an Ideal End-point of Oral Antiviral Therapy in Chronic Hepatitis B Patients? | The Korean Journal of Gastroenterology;: 329-332, 2014. | WPRIM

Main content 1 Search 2 Footer 3

+A A -A High contrast

Is HBsAg Loss an Ideal End-point of Oral Antiviral Therapy in Chronic Hepatitis B Patients? / 대한소화기학회지

Keunhee KANG; Ji-Hoon KIM.

The Korean Journal of Gastroenterology ; : 329-332, 2014.

Article in Ko | WPRIM | ID: wpr-62975

Responsible library: WPRO

ABSTRACT

ABSTRACT

No abstract available.

Subject(s)

Female; Humans; Male; Antiviral Agents/therapeutic use; Carcinoma, Hepatocellular/virology; Hepatitis B Surface Antigens/blood; Hepatitis B, Chronic/blood; Liver Neoplasms/virology

Search on Google

Full text: 1 Index: WPRIM Main subject: Antiviral Agents / Carcinoma, Hepatocellular / Hepatitis B, Chronic / Hepatitis B Surface Antigens / Liver Neoplasms Limits: Female / Humans / Male Language: Ko Journal: The Korean Journal of Gastroenterology Year: 2014 Type: Article

Search on Google

Full text: 1 Index: WPRIM Main subject: Antiviral Agents / Carcinoma, Hepatocellular / Hepatitis B, Chronic / Hepatitis B Surface Antigens / Liver Neoplasms Limits: Female / Humans / Male Language: Ko Journal: The Korean Journal of Gastroenterology Year: 2014 Type: Article